ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors
December 03, 2021ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company and Navigo Proteins GmbH, a premier protein engineering company developing optimized scaffold protein-based affinity ligands... -
ITM, DCB sign agreement for Targeted Radionuclide Therapy
September 03, 2019The agreement sets out terms concerning the local development, registration and subsequent commercialization by DCB of ITM’s proprietary brand Solucin® for Targeted Radionuclide Therapy (TRT).
Pharma Sources Insight January 2025
